For the first time, researchers have shown how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Their pre-clinical findings may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.
from Top Health News – ScienceDaily http://ift.tt/2rGSIUE
from Tumblr http://ift.tt/2s05ddf
No comments:
Post a Comment